AI Bias Analysis
4 models · Takes ~15 seconds
Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.
Source
Bloomberg Markets
Opens original article in a new tab
Valerie Grimba, director of global ETF strategy at RBC Capital Markets, discusses the evolving ETF landscape with Scarlet Fu and Katie Greifeld on "Bloomberg ETF IQ." (Source: Bloomberg)
Stocks held near record highs at the start of a week that will feature a raft of megacap earnings and central bank decisions, with traders weighing conflicting signs about progress toward ending the Iran war. Kristy Akullian, BlackRock Head of iShares Investment Strategy for the Americas joins Bloomberg Businessweek Daily to discuss the markets and the 2026 Spring Investment Directions Outlook (Source: Bloomberg)
Alyson Shupe, managing director and head of global product strategy at Goldman Sachs Asset Management discusses the current market environment and strategic approaches to product development with Scarlet Fu and Katie Greifeld on "Bloomberg ETF IQ." (Source: Bloomberg)
Activist investor Starboard Value has built a significant stake in Flowserve Corp. and is speaking to the industrial company about potential changes, according to people familiar with the matter.
